Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 26.04B | 25.45B | 23.83B | 21.53B | 18.06B | 17.27B |
Gross Profit | 13.65B | 13.55B | 12.34B | 10.87B | 9.62B | 9.27B |
EBITDA | 13.71B | 12.99B | 12.17B | 10.16B | 9.84B | 8.38B |
Net Income | 3.63B | 3.15B | 2.84B | 1.67B | 2.96B | 1.83B |
Balance Sheet | ||||||
Total Assets | 56.95B | 56.33B | 55.26B | 56.41B | 49.82B | 41.65B |
Cash, Cash Equivalents and Short-Term Investments | 5.47B | 5.69B | 5.04B | 4.74B | 9.80B | 4.65B |
Total Debt | 16.22B | 15.61B | 16.03B | 17.80B | 12.91B | 10.72B |
Total Liabilities | 31.83B | 29.92B | 29.24B | 31.01B | 24.71B | 18.47B |
Stockholders Equity | 25.13B | 26.40B | 26.02B | 25.40B | 25.11B | 23.18B |
Cash Flow | ||||||
Free Cash Flow | 8.97B | 7.78B | 7.92B | 4.70B | 4.62B | 4.78B |
Operating Cash Flow | 13.47B | 12.33B | 12.42B | 9.43B | 9.91B | 8.67B |
Investing Cash Flow | -5.58B | -4.95B | -4.68B | -8.62B | -6.52B | -5.29B |
Financing Cash Flow | -7.00B | -7.20B | -7.21B | -3.49B | -735.37M | -3.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $19.69B | 19.61 | 8.20% | 3.59% | -6.51% | -0.21% | |
79 Outperform | $9.94B | 15.69 | 13.78% | 5.81% | -7.99% | 2.16% | |
78 Outperform | $5.06B | 11.40 | 7.38% | 5.60% | 19.25% | 5.96% | |
74 Outperform | $9.67B | 15.79 | 3.81% | 3.60% | -1.22% | -19.08% | |
68 Neutral | $8.60B | 12.03 | 11.08% | 4.43% | -4.74% | -16.23% | |
60 Neutral | $31.43B | ― | -3.55% | 6.42% | -4.73% | -251.31% | |
56 Neutral | HK$67.91B | 0.87 | -5.00% | 5.18% | -0.87% | -12.66% |